Given the observations that MHC-I expression is frequently downregulated in GBM38 to evade antigen-specific T-cell killing, an MHC-independent strategy involving the NKG2D BiTE may repurpose many of the TILs present in the tumor microenvironment (TME). The gene discussed is HLA-C; the disease is neoplasm.